gyki 52466 and gyki 53655

gyki 52466 has been researched along with gyki 53655 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, AM; Hesson, DP; Jones, KA; Pelletier, JC1
Baraldi, M; De Micheli, C; De Sarro, A; De Sarro, G; Grasso, S; Micale, N; Puia, G; Zappalà, M1
Huettner, JE; Wilding, TJ1
Lerma, J; Morales, M; Paternain, AV1
Ballyk, BA; Bath, CP; Bleakman, D; Bufton, HR; Kamboj, RK; Lodge, D; Palmer, AJ; Schoepp, DD; Sharpe, EF; Tarnawa, I; Woolley, ML1
Gacsályi, I; Gigler, G; Gyertyán, I; Lévay, G; Szabados, T2
Ciprian-Ollivier, J; Perret, L; Sebban, C; Spedding, M; Tesolin-Decros, B1
Nowak, LM; Oswald, RE; Ptak, CP; Shi, EY; Sipple, MT; Srinivasan, J; Yuan, CL1

Other Studies

9 other study(ies) available for gyki 52466 and gyki 53655

ArticleYear
Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor.
    Journal of medicinal chemistry, 1996, Jan-19, Volume: 39, Issue:2

    Topics: Animals; Cells, Cultured; Humans; Kidney Cortex; Phthalazines; Rats; Receptors, AMPA

1996
Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
    Journal of medicinal chemistry, 1999, Oct-21, Volume: 42, Issue:21

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Cells, Cultured; Convulsants; Drug Evaluation, Preclinical; Electroshock; Excitatory Amino Acid Antagonists; Kainic Acid; Male; Mice; Mice, Inbred DBA; Motor Activity; Neurons; Patch-Clamp Techniques; Pentylenetetrazole; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Seizures

1999
Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    Molecular pharmacology, 1995, Volume: 47, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Binding, Competitive; Cerebral Cortex; Concanavalin A; Electrophysiology; Ganglia, Spinal; Kainic Acid; Membrane Potentials; Neurons; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Kainic Acid; Substrate Specificity

1995
Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons.
    Neuron, 1995, Volume: 14, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Cells, Cultured; Electric Conductivity; Hippocampus; Kainic Acid; Neuronal Plasticity; Neurons; Rats; Receptors, AMPA; Receptors, Kainic Acid; Synaptic Transmission

1995
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
    Neuropharmacology, 1996, Volume: 35, Issue:12

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Cell Line; Cerebellum; Cerebral Cortex; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Humans; Kidney; Membrane Potentials; Molecular Structure; Neurons; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recombinant Proteins; Spinal Cord; Structure-Activity Relationship; Transfection

1996
Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
    Neurobiology (Budapest, Hungary), 1999, Volume: 7, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Mice; Muscle Relaxants, Central

1999
Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.
    Brain research bulletin, 2001, Volume: 55, Issue:3

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Ischemia; Dose-Response Relationship, Drug; Electroshock; Magnesium Chloride; Male; Mice; Mice, Inbred Strains; Neuroprotective Agents; Seizures; Survival Analysis; Time Factors

2001
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Clozapine; Consciousness; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Fluorobenzenes; Hallucinogens; Male; Models, Biological; Phencyclidine; Piperidines; Prazosin; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Serotonin; Serotonin Antagonists

2002
Noncompetitive antagonists induce cooperative AMPA receptor channel gating.
    The Journal of general physiology, 2019, 02-04, Volume: 151, Issue:2

    Topics: Benzodiazepines; Binding Sites; Excitatory Amino Acid Antagonists; HEK293 Cells; Humans; Ion Channel Gating; Protein Binding; Receptors, AMPA

2019